Vaccine Trials Target Leading Cause of Diarrheal Disease Deaths

Why it matters locally: The development of a Shigella vaccine could have a significant public health impact in Nevada, particularly in reducing the incidence of diarrheal diseases among vulnerable populations, including young children. State and local health agencies, such as the Southern Nevada Health District, monitor infectious disease outbreaks and could utilize such a vaccine to improve community health outcomes.

Medical researchers are conducting trials for a new vaccine designed to combat Shigella bacteria. Shigella represents a primary cause of diarrheal disease globally. Diarrheal diseases result in over one million deaths each year. Children under the age of five account for nearly half of these fatalities. The development of this vaccine offers a potential intervention against this widespread health issue.